The use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga municipality, northern Ghana
Open Access
- 31 July 2013
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 12 (1) , 266
Abstract
Background: The use of non-prescribed anti-malarial drugs can lead to treatment failure and development of drug-resistant parasites. This study investigated the use of non-prescribed anti-malarial drugs for the treatment of malaria in the Bolgatanga Municipality of northern Ghana. Methods: This was a cross-sectional survey of a random sample of 392 adults and children with episodes of malaria in the last four weeks prior to the study. Results: Majority of survey respondents 96.9% (380) knew the symptoms of malaria, 75% (294) knew the causes of malaria and 93.1% (365) were aware of mode of transmission of malaria. The use of non-prescribed anti-malarial drugs was 16.8% (95% CI: 13.3-21.0) among the respondents. About 56% (95% CI: 43.3-68.3) of the respondents who took non-prescribed anti-malaria drugs took non-artemisinin-based combination therapy (chloroquine, artemether, amodiaquine and sulphadoxine-pyrimethamine). Respondents above five years of age were more likely to use non-prescribed anti-malarial drugs than those below five years of age [P < 0.001]; respondents who knew the right source of malaria treatment were less likely to use non-prescribed anti-malarial drugs than those who did not [P = 0.002]. Respondents using non-prescribed anti-malarials were influenced by people around them who used non-prescribed anti-malarials. Thus, these respondents were more likely to use non-prescribed anti-malarials than those who were not influenced [P = 0.004]. Conclusions: Respondents’ knowledge of malaria treatment and the influence of people using non-prescribed anti-malarials are factors affecting use of non-prescribed anti-malarials. The study concludes that there is high use of non-prescribed anti-malarial drugs in the municipality and most of the non-prescribed anti-malarias were non-artemisinin-based combination therapy. The study recommends education of the general public and chemical sellers to reduce the use of non-prescribe anti-malaria drugs.Keywords
This publication has 22 references indexed in Scilit:
- Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast AsiaClinical Infectious Diseases, 2010
- Is community-based health insurance an equitable strategy for paying for healthcare? Experiences from southeast NigeriaHealth Policy, 2009
- Why most Togolese people do not seek care for malaria in health care facilities: A theory-driven inventory of reasonsPsychology, Health & Medicine, 2009
- Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural SenegalMalaria Journal, 2009
- Malaria treatment in the retail sector: Knowledge and practices of drug sellers in rural TanzaniaBMC Public Health, 2008
- Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand BorderEmerging Infectious Diseases, 2008
- Artesunate–amodiaquine for the treatment of uncomplicated malariaExpert Opinion on Investigational Drugs, 2007
- Prevention of Increasing Rates of Treatment Failure by Combining Sulfadoxine‐Pyrimethamine with Artesunate or Amodiaquine for the Sequential Treatment of MalariaThe Journal of Infectious Diseases, 2003
- Malaria: Ethnomedical perceptions and practice in an Adangbe farming community and implications for controlSocial Science & Medicine, 1992
- Plasmodium falciparum: sensitivity to chloroquine in vivo in three ecological zones in GhanaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992